Crossref
Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy
Transfuze a hematologie dnes · 15.06.2026 · 32 (2)
DOI: 10.48095/cctahd202610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfuze a hematologie dnes, online erschienen am 15.06.2026. Verfasst von Anna Panovská.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Panovská, A. (2026). Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy. Transfuze a hematologie dnes, 32(2). https://doi.org/10.48095/cctahd202610
Vancouver
Panovská A. Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy. Transfuze a hematologie dnes. 2026;32(2). doi:10.48095/cctahd202610
BibTeX
@article{Panovsk2026,
author = {Panovská, Anna},
title = {Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy},
journal = {Transfuze a hematologie dnes},
year = {2026},
volume = {32},
number = {2},
doi = {10.48095/cctahd202610}
}
EUVIMED